News Snapshot:
China has consistently advanced the research and development (R&D) of COVID-19 vaccines among the BRICS countries, spearheading the global fight against the pandemic. It is the first country to propose COVID-19 vaccine as a global public good, the first to support vaccine intellectual property rights exemption and the first to carry out cooperation in vaccine production with developing countries, playing a positive role in boosting steady economic recovery for all countries. Chinese biopharmaceutical company Sinovac has made progress in the joint R&D as well as collaborative production of COVID-19 vaccines with BRICS countries. Since June 2020, Sinovac has carried out...
